A 2025 analysis published in The Lancet found that selective serotonin reuptake inhibitors (SSRIs) tended to have fewer physical cardiovascular and metabolic side effects than some older antidepressant classes.
October 23, 2025
high
temporal
Comparative side-effect profile between SSRI class and older antidepressants.